sglt2 inhibitors vs glp-1 agonists Common systemic effects of either or GLP-1R SGLT2 vs GLP-1 for CKD:

In 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid (MPTP/P)-induced Parkinsons disease model mice, MPTP/P injection increased the ratio of Bax/Bcl-2 and the expression of caspase-3 in the hippocampus, while berberine administration reversed these effects (Kim et al., 2014)

It works deeply at the cellular level to reduce pigmentation, manage oxidative stress, and support collagen protection

We treat it like medicine, which means saying no when the patient isnt ready, monitoring closely when they are, and adjusting protocols based on what bloodwork shows rather than what the patient wants to hear

reported that SLC7A11 expression is upregulated in both Sugen5416/hypoxia-induced PAH rat models and in patients with PAH